Ropes Wealth Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Ropes Wealth Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-120	Closed	-$5K	–	856
2020 Q4	$5K	Hold	120	–	–	﹤0.01%	578
2020 Q3	$7K	Hold	120	–	–	﹤0.01%	547
2020 Q2	$8K	Hold	120	–	–	﹤0.01%	467
2020 Q1	$6K	Hold	120	–	–	﹤0.01%	451
2019 Q4	$10K	Hold	120	–	–	﹤0.01%	470
2019 Q3	$6K	Hold	120	–	–	﹤0.01%	509
2019 Q2	$6K	Hold	120	–	–	﹤0.01%	515
2019 Q1	$6K	Hold	120	–	–	﹤0.01%	480
2018 Q4	$5K	Hold	120	–	–	﹤0.01%	460
2018 Q3	$5K	Buy	+120	New	+$5.32K	﹤0.01%	494

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ropes Wealth Advisors's GBT Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 120 shares — an estimated $5K sold.

Ropes Wealth Advisors first reported a position in GBT in Q3 2018 and held it in 10 quarters. The position peaked at $10K in Q4 2019. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

Ropes Wealth Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 120 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $5K.
Ropes Wealth Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and held it in 10 quarters.
Ropes Wealth Advisors's Global Blood Therapeutics, Inc. position peaked at $10K in Q4 2019.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.